DATATRAK International, Inc. (DTRK)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 7 | 6 | 6 | 6 | 7 | 7 | 6 | - |
| Operating profit | $m | 2 | -1 | ||||||
| Net profit | $m | -0 | -0 | -1 | 3 | 11 | 3 | -1 | - |
| EPS reported | $ | 0.06 | -0.35 | ||||||
| Operating cashflow per share | $ | 0.03 | 0.03 | ||||||
| Capex per share | $ | 0.03 | 0.03 | ||||||
| FCF per share | $ | 0.01 | 0.01 | ||||||
| Free cash flow | $m | 0 | -11 | ||||||
| Net debt | $m | -1 | 0 | ||||||
| Book value equity | $m | 6 | 1 | ||||||
| Book value per share | $ | 0.14 | 0.47 | ||||||
| Number of shares | m | 44.67 | 2.81 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 6.17 | - | ||||||
| P/B LTM | x | 1.58 | 7.54 | ||||||
| P/S LTM | x | 1.38 | 1.67 | ||||||
| P/FCF LTM | x | 63.68 | -0.88 | ||||||
| EV/EBITDA LTM | x | 4.54 | -94.79 | ||||||
| EV/Sales LTM | x | 1.37 | 0.02 | ||||||
| Earnings Yield LTM | % | +16.21% | +58.82% | ||||||
| FCF Yield | % | +1.57% | -113.46% | ||||||
| Quality | |||||||||
| ROE | % | +42.57% | +36.67% | ||||||
| ROIC | % | +17.83% | +17.83% | ||||||
| Operating margin | % | +29.38% | +29.38% | ||||||
| Gross margin | % | +81.16% | +81.16% | ||||||
| FCF/Sales | % | +2.17% | +2.17% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -81.82% | - | ||||||
| Sales Growth YoY | % | +7.57% | -11.37% | ||||||
| Net Income Growth YoY | % | -76.55% | - | ||||||
| FCF Growth | % | -87.69% | - | ||||||
| Operating Profit Growth | % | +5.63% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 7.42 | -15.00 | ||||||
| Net Debt/EBITDA | x | -0.04 | -0.04 | ||||||
| EBIT/Net interest | x | 364.46 | 364.46 | ||||||
| Net debt/market cap | % | +0.21% | +9.67% | ||||||
| Net debt/Equity | x | -0.16 | 0.09 | ||||||
| Gross debt/equity | x | 0.00 | 0.57 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
DATATRAK International, Inc. delivers advanced technology and comprehensive service offerings tailored for the clinical research industry. Its flagship offering, DATATRAK ONE Unified Experience, is an integrated clinical enterprise platform empowering clinical professionals and service providers to efficiently design, execute, and oversee clinical trials. This robust suite features specialized modules such as UX CTMS 360 for trial planning and administration, UX Trial to streamline the design-to-deployment workflow, UX EDC & Medical Coding for secure data capture and delivery, and UX Randomization and Trial Supply Management for automating patient assignment and logistics. Further components include UX Patient Data Capture, UX Safety, and UX Training, which facilitates user education and certification tracking. Additionally, DATATRAK provides Clinical Consulting Services, offering expert training, ongoing support, a dedicated learning center, Software-as-a-Service hosting, adherence to industry standards, and bespoke trial design assistance. The company serves a diverse clientele, including contract research organizations, pharmaceutical and biotechnology firms, and medical device companies engaged in clinical studies. Founded in 1991, DATATRAK International, Inc. is headquartered in Mayfield Heights, Ohio.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
DATATRAK International, Inc. delivers advanced technology and comprehensive service offerings tailored for the clinical research industry. Its flagship offering, DATATRAK ONE Unified Experience, is an integrated clinical enterprise platform empowering clinical professionals and service providers to efficiently design, execute, and oversee clinical trials. This robust suite features specialized modules such as UX CTMS 360 for trial planning and administration, UX Trial to streamline the design-to-deployment workflow, UX EDC & Medical Coding for secure data capture and delivery, and UX Randomization and Trial Supply Management for automating patient assignment and logistics. Further components include UX Patient Data Capture, UX Safety, and UX Training, which facilitates user education and certification tracking. Additionally, DATATRAK provides Clinical Consulting Services, offering expert training, ongoing support, a dedicated learning center, Software-as-a-Service hosting, adherence to industry standards, and bespoke trial design assistance. The company serves a diverse clientele, including contract research organizations, pharmaceutical and biotechnology firms, and medical device companies engaged in clinical studies. Founded in 1991, DATATRAK International, Inc. is headquartered in Mayfield Heights, Ohio.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free